Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,462 | 433 | 99.8% |
| Education | $18.36 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,293 | 47 | $0 (2024) |
| Lilly USA, LLC | $1,238 | 64 | $0 (2024) |
| Novo Nordisk Inc | $1,006 | 48 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $523.70 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $473.57 | 18 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $420.18 | 21 | $0 (2024) |
| Dexcom, Inc. | $418.10 | 21 | $0 (2024) |
| Abbott Laboratories | $375.00 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $369.40 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $356.19 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,109 | 101 | Lilly USA, LLC ($423.57) |
| 2023 | $2,397 | 120 | Lilly USA, LLC ($366.63) |
| 2022 | $2,064 | 97 | Amgen Inc. ($343.42) |
| 2021 | $911.22 | 43 | Novo Nordisk Inc ($99.03) |
| 2020 | $896.28 | 51 | Amgen Inc. ($172.60) |
| 2019 | $342.56 | 10 | SANOFI-AVENTIS U.S. LLC ($99.63) |
| 2018 | $579.77 | 6 | Amgen Inc. ($218.03) |
| 2017 | $181.89 | 7 | Amgen Inc. ($87.10) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.11 | General |
| 11/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 11/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Diabetes | ||||||
| 10/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $20.75 | General |
| 09/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Bone Health | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes Care | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,276 | 2,056 | $223,660 | $72,500 |
| 2022 | 22 | 1,141 | 1,887 | $194,796 | $59,750 |
| 2021 | 25 | 1,653 | 2,238 | $222,305 | $71,653 |
| 2020 | 21 | 1,382 | 1,699 | $175,410 | $51,795 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 285 | $78,090 | $26,748 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 105 | $38,745 | $13,569 | 35.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $14,728 | $4,344 | 29.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 46 | 47 | $14,053 | $4,151 | 29.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 128 | 214 | $13,268 | $3,522 | 26.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 162 | 313 | $3,443 | $2,629 | 76.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 63 | 89 | $9,790 | $2,582 | 26.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 124 | 213 | $8,307 | $2,205 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,106 | $1,928 | 27.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 26 | 69 | $6,348 | $1,797 | 28.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 48 | 71 | $2,485 | $1,774 | 71.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 52 | 96 | $6,048 | $1,594 | 26.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 108 | 177 | $5,841 | $1,565 | 26.8% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 27 | 33 | $5,049 | $1,335 | 26.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 48 | 72 | $3,600 | $944.64 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 98 | $3,528 | $932.96 | 26.4% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 11 | 14 | $840.00 | $223.58 | 26.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 21 | 28 | $812.00 | $213.08 | 26.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 32 | 35 | $665.00 | $177.80 | 26.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 22 | 23 | $483.00 | $130.18 | 27.0% |
| 82340 | Urine calcium level | Office | 2023 | 12 | 14 | $266.00 | $82.74 | 31.1% |
| 81050 | Urine volume measurement | Office | 2023 | 13 | 15 | $165.00 | $53.55 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 256 | $70,144 | $22,756 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 80 | $29,520 | $10,265 | 34.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 38 | 39 | $11,661 | $3,399 | 29.2% |
About Dr. Radhika Chugh, M.D
Dr. Radhika Chugh, M.D is a Internal Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1427398247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radhika Chugh, M.D has received a total of $9,481 in payments from pharmaceutical and medical device companies, with $2,109 received in 2024. These payments were reported across 435 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,462).
As a Medicare-enrolled provider, Chugh has provided services to 5,452 Medicare beneficiaries, totaling 7,880 services with total Medicare billing of $255,698. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 02/15/2013
- Last Updated 03/16/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427398247
Products in Payments
- JARDIANCE (Drug) $710.18
- EVENITY (Biological) $690.87
- Kerendia (Drug) $523.70
- Ozempic (Drug) $452.50
- Dexcom G6 Transmitter (Medical Supply) $378.76
- MOUNJARO (Drug) $355.79
- Repatha (Biological) $345.10
- LEQVIO (Drug) $341.65
- STRENSIQ (Biological) $314.14
- FREESTYLE LIBRE 3 (Device) $301.95
- Rybelsus (Drug) $282.86
- Korlym (Drug) $255.97
- GVOKE HYPOPEN (Drug) $233.82
- TRULICITY (Drug) $183.88
- Vascepa (Drug) $163.48
- GVOKE PFS (Drug) $158.09
- TEPEZZA (Drug) $147.60
- FARXIGA (Drug) $139.00
- SOMAVERT (Drug) $136.34
- ENTRESTO (Drug) $131.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078